Castle Biosciences Inc (CSTL)
27.33
-0.15
(-0.55%)
USD |
NASDAQ |
Dec 24, 11:27
Castle Biosciences Shareholders Equity (Quarterly): 441.06M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Delcath Systems Inc | 8.571M |
| Star Equity Holdings Inc | 58.37M |
| Exact Sciences Corp | 3.211B |
| CytoSorbents Corp | 13.00M |
| Progyny Inc | 434.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 514.56M |
| Total Liabilities (Quarterly) | 73.51M |
| Debt to Equity Ratio | 0.0227 |
| Current Ratio | 7.784 |
| Net Debt Paydown Yield | -0.25% |